NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00002615,Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer,https://clinicaltrials.gov/study/NCT00002615,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not known whether receiving chemotherapy before surgery may be more effective than surgery alone in treating patients with stomach cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of surgery plus combination chemotherapy with surgery alone in treating patients with stomach cancer.",NO,Gastric Cancer,DRUG: cisplatin|DRUG: epirubicin hydrochloride|DRUG: fluorouracil|PROCEDURE: conventional surgery,,,,Medical Research Council,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,500,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,CDR0000063914|MRC-ST02|EU-94035,1994-06,,2003-12,2003-01-27,,2013-12-19,"Epsom General Hospital, Epsom, Surrey, KT18 7EG, United Kingdom",
